Is blood obsolete?

Journal of Trauma - Injury, Infection and Critical Care

Volumn 42, Issue 4, 1997, Pages 730-732

  Cohn, Stephen M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SUBSTITUTE; DIASPIRIN CROSSLINKED HEMOGLOBIN; HEMOGLOBIN; HEMOGLOBIN DERIVATIVE; POLYMERIZED HEMOGLOBIN; RECOMBINANT HEMOGLOBIN; UNCLASSIFIED DRUG;

BLEEDING; BLOOD SUBSTITUTION; BLOOD TRANSFUSION; CLINICAL TRIAL; COST BENEFIT ANALYSIS; HUMAN; NOTE; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL;

EID: 0030943442     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/00005373-199704000-00025     Document Type: Note

References (12)

1. Winslow RM. Hemoglobin-Based Red Cell Subsumes Baltimore, Md: The Johns Hopkins University Press 1992.
2. VonStark G. Die Resorborbarkeit Des Haimatins Und Die Bedeutungder Haemoglobin-Preparate. Disch Med Wochenschr. 1898;24:805-808.
3. Amberson WR, Jennings JJ, Rhode CM. Clinical experience with hemoglobin-saline solutions. J Appl Physiol. 1949; 1:469-489.
4. Pivotal Clinical Trials of Blood Substitutes Begin. Biotechnology News. 1995;15:2-6.
5. Stover & Associates, LLC. A New Generation of Oxygen Therapeutics. Stamford, CT; 1996.
6. Gulati A, Sharma AC, Singh G. Regional circulatory effects of diaspirin crosslinked hemoglobin can be blocked by the endothelin antagonist, BQ-123. FASEB J. 1994;8:A62. Abstract.
7. McKenzie JE, Scandlind DM, Ahle NW. Diaspinn cross-linked hemoglobin (DCLHb): Improvement in regional blood flow following administration in hypovolemic shock in swine. ISBS Program & Abstracts. 1993.
8. Przybelski RJ, Daily EK, Kisicki JC, Mattia-Goldberg C, Bounds MJ, Colburn WA. Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution. Crit Care Med. 1996;24:1993-2000.
9. Gould SA, Moore EE, Moore FA, et al. The clinical utility of human polymerized hemoglobin as a blood substitute following trauma and emergent surgery. J Trauma. 1993; 39:157. Abstract.
10. Hughes GS, Antal EJ, Locker PK, Francom SF, Adams WJ, Jacobs EE. Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans. Crit Care Med. 1996;24:756-764.
11. Collinge J. New diagnostic tests for prion diseases. N Engl J Med. 1996;335:963-965.
12. Wahr JA, Levy JH, Kindsher J, et al. Hemodynamic effects of a bovine hemoglobin based oxygen carrying solution: I. Surgical patients. Anesthesiology. 1996;V85:A347. Abstract.